Evidence map›Paper›PMID 39514844›Full record

ReviewRevista medica del Instituto Mexicano del Seguro Social2024

[Dual kidney transplantation, report of a case and review of the literature].

Diana Fabiola Fernández-Ánge, Luis García-Covarrubias, Héctor Hinojosa-Heredia, Ma Virgilia Soto, Aldo García-Covarrubias, Héctor Santiago Díliz-Pérez

Abstract readCase ReportsReviewEnglish Abstract
In one paragraph

Review in Revista medica del Instituto Mexicano del Seguro Social, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Diana Fabiola Fernández-ÁngeSecretaría de Salud, Hospital General de México "Dr. Eduardo Liceaga", Departamento de Cirugía General. Ciudad de México, México.ORCID 0000-0001-6529-9347a
Luis García-CovarrubiasInstituto Mexicano del Seguro Social, Centro Médico Nacional Siglo XXI, Hospital de Especialidades "Dr. Bernardo Sepúlveda Gutiérrez", Servicio de Gastrocirugía. Ciudad de México, México.ORCID 0000-0003-3687-5397b
Héctor Hinojosa-HerediaSecretaría de Salud, Hospital General de México "Dr. Eduardo Liceaga", Servicio de Nefrología. Ciudad de México, México.ORCID 0000-0003-4259-3708c
Ma Virgilia SotoSecretaría de Salud, Hospital General de México "Dr. Eduardo Liceaga", Departamento de Patología. Ciudad de México, México.ORCID 0000-0001-8277-7507d
Aldo García-CovarrubiasSecretaría de Salud, Hospital General de México "Dr. Eduardo Liceaga", Servicio de Trasplantes, Ciudad de México, México.ORCID 0000-0002-4014-5314e
Héctor Santiago Díliz-PérezSecretaría de Salud, Hospital General de México "Dr. Eduardo Liceaga", Servicio de Trasplantes, Ciudad de México, México.ORCID 0009-0007-5699-076Xf

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: Kidney transplant is the best replacement therapy for kidney function; However, donors are insufficient, so extended criteria donors (ECD) are needed, which, in well-selected recipients, provide better survival than being on dialysis. Dual kidney transplantation (DRT) should be offered to elderly patients with lower immunological risk and with a lower body mass index. DCE are considered donors who died due to stroke, ≥ 60 years old or aged between 50 and 59 years, with diabetes or previous hypertension, clinical proteinuria, estimated glomerular filtration rate (eGFR) between 30 and 60 mL/min, or Terminal serum creatinine > 2.5 mg/dL. Clinical case: 57-year-old male patient undergoing TRD of a 67-year-old DCE, with creatinine of 2 mg/dL at the time of extraction, without previous pathologies, with eGFR: 34 mL/min, KDPI: 92% , KDRI: 1.64, Remuzzi pre-implantation biopsy 5, with 14-hour cold ischemia. He was discharged on the eighth day with a creatinine of 1 mg/dL. At 45 months with creatinine of 0.9 mg/dL, and eGFR by CKD-EPI of 91 mL/min/ 1.73m2. Conclusion: TRD is an alternative for ECD grafts. The "old for old" strategy allows TRD in older recipients a better survival than being on replacement treatment. The correlation with the KDRI, KDPI scales and the preimplantation biopsy according to the Remuzzi score improves transplant results by discarding kidneys with severe histopathological alterations, this can help reduce the rate of discarding SCAD and kidneys.

Indexed as

Kidney TransplantationAgedHumansMaleMiddle AgedTissue DonorsKidney TransplantationRenal Replacement TherapySurgical Procedures, Operative

Identifiers

PMID39514844
PMCPMC12148113

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.